NASDAQ:BWAY

BrainsWay (BWAY) Stock Forecast, Price & News

$2.23

+0.13 (+6.19%)

(As of 06/7/2023 ET)

Compare

Today's Range: $2.10
▼
$2.28
50-Day Range: $1.46
▼
$2.10
52-Week Range: $1.38
▼
$7.00

Volume: 232,058 shs
Average Volume: 75,633 shs
Market Capitalization: $36.97 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.67

BrainsWay MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 199.0% Upside
$6.67 Price Target
Short Interest: Healthy
0.04% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.25
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.25) to ($0.16) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

327th out of 981 stocks

Surgical & Medical Instruments Industry

33rd out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
BrainsWay has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.67, BrainsWay has a forecasted upside of 199.0% from its current price of $2.23.
Amount of Analyst Coverage
BrainsWay has only been the subject of 1 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
0.04% of the outstanding shares of BrainsWay have been sold short.
Short Interest Ratio / Days to Cover
BrainsWay has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in BrainsWay has recently decreased by 2.78%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
BrainsWay does not currently pay a dividend.
Dividend Growth
BrainsWay does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BWAY.

1.0

News and Social Media Coverage

News Sentiment
BrainsWay has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for BrainsWay this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for BWAY on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BrainsWay insiders have not sold or bought any company stock.
Percentage Held by Insiders
19.00% of the stock of BrainsWay is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
47.94% of the stock of BrainsWay is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for BrainsWay are expected to grow in the coming year, from ($0.25) to ($0.16) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of BrainsWay is -5.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of BrainsWay is -5.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
BrainsWay has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About BrainsWay (NASDAQ:BWAY) Stock

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

June 5, 2023 | markets.businessinsider.com

The Latest Analyst Ratings for BrainsWay

June 5, 2023 | markets.businessinsider.com

H.C. Wainwright Keeps Their Buy Rating on Brainsway (BWAY)

June 8, 2023 | UNKNOWN (Ad)

This Company Is Solving A Multi-Billion Dollar Problem!

This Little Known NASDAQ Stock is Solving a Multi-Billion Dollar Problem!

May 23, 2023 | markets.businessinsider.com

BrainsWay Appoints Ido Marom To Succeed Scott Areglado As CFO

May 23, 2023 | msn.com

BrainsWay appoints CFO

May 23, 2023 | finance.yahoo.com

BrainsWay Announces Appointment of Ido Marom as CFO

May 23, 2023 | americanbankingnews.com

Equities Analysts Set Expectations for BrainsWay Ltd.'s FY2023 Earnings (NASDAQ:BWAY)

May 22, 2023 | americanbankingnews.com

BrainsWay (NASDAQ:BWAY) Given New $3.00 Price Target at Raymond James

June 8, 2023 | UNKNOWN (Ad)

The Stock That's Brining Lithium Back To America!

The American Energy Crisis Is Very Real And This Stock Is Solving That Problem On U.S Soil

May 18, 2023 | markets.businessinsider.com

BrainsWay - Aiming For Revenue Growth And Profitability

May 17, 2023 | msn.com

BrainsWay: Q1 Earnings Insights

May 16, 2023 | msn.com

Earnings Outlook For BrainsWay

May 16, 2023 | americanbankingnews.com

BrainsWay (BWAY) Set to Announce Quarterly Earnings on Wednesday

May 12, 2023 | finance.yahoo.com

Brainsway Ltd. Sponsored ADR (BWAY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

May 11, 2023 | americanbankingnews.com

Short Interest in BrainsWay Ltd. (NASDAQ:BWAY) Decreases By 64.2%

May 6, 2023 | ca.finance.yahoo.com

BrainsWay Ltd. (BWAY) Stock Historical Prices & Data - Yahoo Finance

May 3, 2023 | finance.yahoo.com

BrainsWay to Report First Quarter 2023 Financial Results on May 17, 2023

May 2, 2023 | finance.yahoo.com

BrainsWay to Participate in Clinical TMS Society and American Psychiatric Association Meetings

April 19, 2023 | yahoo.com

Smash, the Canceled TV Musical, to Become a Broadway Musical (For Real)

April 18, 2023 | americanbankingnews.com

HC Wainwright Weighs in on BrainsWay Ltd.'s FY2024 Earnings (NASDAQ:BWAY)

April 14, 2023 | americanbankingnews.com

BrainsWay (NASDAQ:BWAY) Price Target Cut to $12.00

April 14, 2023 | americanbankingnews.com

BrainsWay (NASDAQ:BWAY) versus Akili (NASDAQ:AKLI) Head to Head Review

March 29, 2023 | marketwatch.com

BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS(TM) in Treating Depression and Anxious Depression

March 29, 2023 | finance.yahoo.com

BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression

March 29, 2023 | americanbankingnews.com

Oppenheimer Comments on BrainsWay Ltd.'s Q1 2023 Earnings (NASDAQ:BWAY)

March 28, 2023 | finance.yahoo.com

BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression

March 22, 2023 | americanbankingnews.com

Research Analysts Set Expectations for BrainsWay Ltd.'s Q1 2023 Earnings (NASDAQ:BWAY)

See More Headlines

BWAY Price History

30 days | 90 days | 365 days | Advanced Chart

BWAY Company Calendar

Last Earnings: 3/15/2023
Today: 6/07/2023
Next Earnings (Estimated): 8/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BWAY
CUSIP: N/A
CIK: 1505065
Web: www.brainsway.com
Phone: (722) 582-4030
Fax: N/A
Employees: 100
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $6.67
High Stock Price Forecast: $12.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +195.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.41)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,350,000.00
Net Margins: -53.37%
Pretax Margin: -52.21%
Return on Equity: -28.89%
Return on Assets: -20.74%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.13
Quick Ratio: 5.61

Sales & Book Value

Annual Sales: $27.18 million
Price / Sales: 1.38
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.75 per share
Price / Book: 0.82

Miscellaneous

Outstanding Shares: 16,580,000
Free Float: 13,430,000
Market Cap: $37.47 million
Optionable: Not Optionable
Beta: 0.94

Key Executives

Hadar Levy
Chief Executive Officer

Richard Scott Areglado
Chief Financial Officer & Senior Vice President

Yiftach Roth
Chief Scientific Officer

Moria Ben Soussan Ankri
Vice President-Research & Development

Aron Tendler
Chief Medical Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BWAY Stock - Frequently Asked Questions

Should I buy or sell BrainsWay stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BWAY shares.
View BWAY analyst ratings or view top-rated stocks.
What is BrainsWay's stock price forecast for 2023?: 3 analysts have issued twelve-month price targets for BrainsWay's stock. Their BWAY share price forecasts range from $3.00 to $12.00. On average, they predict the company's stock price to reach $6.67 in the next twelve months. This suggests a possible upside of 195.0% from the stock's current price.
View analysts price targets for BWAY or view top-rated stocks among Wall Street analysts.
How have BWAY shares performed in 2023?: BrainsWay's stock was trading at $2.47 at the start of the year. Since then, BWAY stock has decreased by 8.5% and is now trading at $2.26.
View the best growth stocks for 2023 here.
When is BrainsWay's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our BWAY earnings forecast.
How were BrainsWay's earnings last quarter?: BrainsWay Ltd. (NASDAQ:BWAY) posted its earnings results on Wednesday, March, 15th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.12). The business earned $6.03 million during the quarter, compared to analysts' expectations of $6.10 million. BrainsWay had a negative trailing twelve-month return on equity of 28.89% and a negative net margin of 53.37%.
What other stocks do shareholders of BrainsWay own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BrainsWay investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Pfizer (PFE), Neuronetics (STIM), Boingo Wireless (WIFI), Ampio Pharmaceuticals (AMPE), Eastman Chemical (EMN), Enbridge (ENB) and Energy Transfer (ET).

When did BrainsWay IPO?: (BWAY) raised $30 million in an initial public offering on Wednesday, April 17th 2019. The company issued 2,500,000 shares at a price of $11.94 per share. Cantor acted as the underwriter for the IPO.
What is BrainsWay's stock symbol?: BrainsWay trades on the NASDAQ under the ticker symbol "BWAY."
Who are BrainsWay's major shareholders?: BrainsWay's stock is owned by many different institutional and retail investors. Top institutional investors include Wasatch Advisors LP (6.00%), Renaissance Technologies LLC (0.19%) and Good Life Advisors LLC (0.11%).
How do I buy shares of BrainsWay?: Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is BrainsWay's stock price today?: One share of BWAY stock can currently be purchased for approximately $2.26.
How much money does BrainsWay make?: BrainsWay (NASDAQ:BWAY) has a market capitalization of $37.47 million and generates $27.18 million in revenue each year. The company earns $-13,350,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.
How can I contact BrainsWay?: BrainsWay's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518. The official website for the company is www.brainsway.com. The company can be reached via phone at (722) 582-4030 or via email at hadarl@brainsway.com.

This page (NASDAQ:BWAY) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial